Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?

被引：19

作者：

Gould, DC ^{[1
]}

Kirby, RS ^{[1
]}

机构：

[1] Prostate Ctr, London W1G 8GT, England

来源：

PROSTATE CANCER AND PROSTATIC DISEASES | 2006年 / 9卷 / 01期

关键词：

testosterone; androgens; dihydrotestosterone; hypogonadism;

D O I：

10.1038/sj.pcan.4500839

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Prescription sales of testosterone have risen considerably over the last decade and are likely to continue to grow as further preparations become available. Testosterone promotes existing prostate cancer; however, concern does exist as to whether or not testosterone therapy induces prostate cancer. The aim of this article is to review the evidence for such a link.

引用

收藏

页码：14 / 18

页数：5

相关论文

共 46 条

[1] Chemoprevention of prostate cancer in men at high risk: Rationale and design of the reduction by dutasteride of prostate cancer events (reduce) trial [J].

Andriole, G ;

Bostwick, D ;

Brawley, O ;

Gomella, L ;

Tindall, D ;

Breed, S ;

Somerville, M ;

Rittmaster, R .

JOURNAL OF UROLOGY, 2004, 172 (04) :1314-1317

[2]

Andriole GL, 2004, UROLOGY, V64, P537, DOI 10.1016/j.urology.2004.04.084

[3] Human prostate cancer risk factors [J].

Bostwick, DG ;

Burke, HB ;

Djakiew, D ;

Euling, S ;

Ho, SM ;

Landolph, J ;

Morrison, H ;

Sonawane, B ;

Shifflett, T ;

Waters, DJ ;

Timms, B .

CANCER, 2004, 101 (10) :2371-2490

[4] LATENT CARCINOMA OF PROSTATE AT AUTOPSY IN 7 AREAS - COLLABORATIVE STUDY ORGANIZED BY INTERNATIONAL-AGENCY-FOR-RESEARCH-ON-CANCER, LYONS, FRANCE [J].

BRESLOW, N ;

CHAN, CW ;

DHOM, G ;

DRURY, RAB ;

FRANKS, LM ;

GELLEI, B ;

LEE, YS ;

LUNDBERG, S ;

SPARKE, B ;

STERNBY, NH ;

TULINIUS, H .

INTERNATIONAL JOURNAL OF CANCER, 1977, 20 (05) :680-688

[5] LONGITUDINAL EVALUATION OF SERUM ANDROGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE-CANCER [J].

CARTER, HB ;

PEARSON, JD ;

METTER, EJ ;

CHAN, DW ;

ANDRES, R ;

FOZARD, JL ;

ROSNER, W ;

WALSH, PC .

PROSTATE, 1995, 27 (01) :25-31

[6] THE LENGTH AND LOCATION OF CAG TRINUCLEOTIDE REPEATS IN THE ANDROGEN RECEPTOR N-TERMINAL DOMAIN AFFECT TRANSACTIVATION FUNCTION [J].

CHAMBERLAIN, NL ;

DRIVER, ED ;

MIESFELD, RL .

NUCLEIC ACIDS RESEARCH, 1994, 22 (15) :3181-3186

[7] Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor [J].

Clark, RV ;

Hermann, DJ ;

Cunningham, GR ;

Wilson, TH ;

Morrill, BB ;

Hobbs, S .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) :2179-2184

[8] Propionibacterium acnes associated with inflammation in radicial prostatectomy specimens:: A possible link to cancer evolution? [J].

Cohen, RJ ;

Shannon, BA ;

McNeal, JE ;

Shannon, T ;

Garrett, KL .

JOURNAL OF UROLOGY, 2005, 173 (06) :1969-1974

[9] Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men [J].

Dobs, AS ;

Meikle, AW ;

Arver, S ;

Sanders, SW ;

Caramelli, KE ;

Mazer, NA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) :3469-3478

[10]

Fenley MR, 2004, ANDROLOGIA, V36, P212

← 1 2 3 4 5 →